Definitive Contract 75D30121C11519
Award Date
7/1/21
Potential Completion Date
9/30/22
Potential Value
$1.7M
Federal Agency
CDC Pittsburgh
Awardee
Marshfield Clinic, Inc.
Ultimate Awardee
Marshfield Clinic Health System, Inc.
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
AJ12 - General Science And Technology R&D Services; General Science And Technology; Applied Research
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Marshfield Clinic has been awarded a definitive cost-no-fee contract valued at $22.6 million by the Centers for Disease Control and Prevention to provide centralized molecular assessment of SARS and influenza virus infections for multi-site prospective cohorts. The contract will support the CDC's efforts to respond to the Coronavirus COVID-19 pandemic through prospective cohort studies and molecular testing of samples from infected individuals. Marshfield Clinic will serve as the prime...
This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Marshfield Clinic, Inc., a non-profit healthcare organization, to enhance the serum repository for Lyme disease. The contract has a ceiling value of $237,421.00 and a completion date of September 24, 2022. Marshfield Clinic has a long history of partnering with the CDC and other federal agencies on public health initiatives, including vaccine safety monitoring and COVID-19 research. This...
This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Marshfield Clinic, Inc., a non-profit healthcare organization, for a project titled "USING ELECTRONIC HEALTH RECORDS TO IDENTIFY AND DESCRIBE". The contract has a ceiling value of $1,029,344.00 and a period of performance ending on September 27, 2027. It is a firm fixed price contract and was not set aside for any particular business type. Marshfield Clinic, Inc. is a subsidiary of...
Marshfield Clinic, Inc. has been awarded a definitive cost-no-fee contract from the Department of Health and Human Services Centers for Disease Control and Prevention valued at up to $424,312. The contract calls for an epidemiologic assessment of Lyme disease diagnoses in electronic health records to support the agency's objectives. As the prime contractor, Marshfield Clinic will analyze Lyme disease data extracted from electronic health records to provide epidemiologic insights. The contract...
This is a firm fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Marshfield Clinic, Inc., a non-profit healthcare organization. The contract, titled "MMR3 LONG TERM FOLLOW UP STUDY", has a ceiling value of $280,051 and an ultimate completion date of June 4, 2022. The contract does not have a set-aside designation. Marshfield Clinic, Inc. is the prime contractor, and there are no subcontractors mentioned. This contract is part of the Vaccine...
This federal contract award to Marshfield Clinic, Inc., a non-profit healthcare organization, is for the SERUM REPOSITORY project. The contract, awarded by the Centers for Disease Control and Prevention (CDC), has a ceiling value of $1,230,268.00 and is a Definitive Contract with a Firm Fixed Price pricing type. The ultimate completion date is September 24, 2028. This contract is not a set-aside award. Marshfield Clinic, Inc. is the prime contractor, and its parent organization is Marshfield...
This is a federal contract award issued by the Centers for Disease Control and Prevention (CDC) to Marshfield Clinic, Inc., a non-profit healthcare organization in Marshfield, Wisconsin. The $241,487 firm fixed-price contract is for "ENHANCING THE SERUM REPOSITORY FOR LYME DISEASE" and has a period of performance through December 31, 2023. Marshfield Clinic, Inc. is a subsidiary of the parent organization Marshfield Clinic Health System, Inc., which has a significant history of federal...
This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Marshfield Clinic, Inc. for a follow-up study to assess immunogenicity associated with a third dose of the measles-mumps-rubella (MMR) vaccine. The contract has a total potential value of $99,565.00 and a completion date of July 31, 2019. Marshfield Clinic is the only source with access to the cohort of 665 subjects who are clients of the clinic, and the contract is sole-sourced under the...
The Centers for Disease Control and Prevention (CDC) awarded a $658,016 definitive contract to Marshfield Clinic, Inc. for "OPTIMAL STRATEGIES TO ESTIMATE THE RELATIVE EFFECTIVENESS OF INFLUENZA VACCINES". This contract, which has a term ending on March 17, 2025, is not set aside. Marshfield Clinic, Inc., a non-profit healthcare organization, will be providing services related to evaluating the effectiveness of influenza vaccines. This contract is part of a larger Vaccine Safety...
This federal contract award to Marshfield Clinic, Inc. was issued by the Centers for Disease Control and Prevention (CDC) for the Vaccine Safety Datalink project. The $592,008 cost-no-fee delivery order is not a set-aside contract. Marshfield Clinic, a non-profit healthcare organization, holds an Indefinite Delivery/Indefinite Quantity (IDIQ) master contract with the CDC for the Vaccine Safety Datalink program, which has a potential value of $149 million. Under this task order, Marshfield Clinic...